ArcticZymes Technologies ASA (AZT.OL)
NOK 13.58
(-2.3%)
NOK 13.58
(-2.3%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 113.01 Million NOK | -69.97% |
| 2022 | 131.79 Million NOK | 6.21% |
| 2021 | 124.08 Million NOK | 34.41% |
| 2020 | 92.31 Million NOK | 58.22% |
| 2019 | 58.34 Million NOK | 23.09% |
| 2018 | 47.4 Million NOK | 5.91% |
| 2017 | 44.75 Million NOK | -0.91% |
| 2016 | 45.16 Million NOK | 21.82% |
| 2015 | 37.07 Million NOK | 68.63% |
| 2014 | 21.98 Million NOK | 12.17% |
| 2013 | 19.6 Million NOK | -0.48% |
| 2012 | 19.69 Million NOK | -6.89% |
| 2011 | 21.15 Million NOK | -12.66% |
| 2010 | 24.21 Million NOK | 8.25% |
| 2009 | 22.37 Million NOK | -52.24% |
| 2008 | 46.84 Million NOK | -17.84% |
| 2007 | 57.01 Million NOK | -1.3% |
| 2006 | 57.76 Million NOK | 4.16% |
| 2005 | 55.45 Million NOK | -58.63% |
| 2004 | 134.04 Million NOK | 134.36% |
| 2003 | 57.19 Million NOK | 928.13% |
| 2002 | 5.56 Million NOK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 9.13 Million NOK | -2.36% |
| 2024 Q2 | 10.08 Million NOK | 10.47% |
| 2023 Q2 | 27.35 Million NOK | -6.42% |
| 2023 Q1 | 29.23 Million NOK | 9.98% |
| 2023 Q4 | 9.35 Million NOK | -68.96% |
| 2023 FY | 39.57 Million NOK | -69.97% |
| 2023 Q3 | 30.13 Million NOK | 10.15% |
| 2022 Q1 | 47.43 Million NOK | 31.24% |
| 2022 Q2 | 29.02 Million NOK | -38.8% |
| 2022 FY | 131.79 Million NOK | 6.21% |
| 2022 Q3 | 28.75 Million NOK | -0.96% |
| 2022 Q4 | 26.58 Million NOK | -7.54% |
| 2021 Q3 | 24.9 Million NOK | 10.3% |
| 2021 Q2 | 22.57 Million NOK | -44.2% |
| 2021 FY | 124.08 Million NOK | 34.41% |
| 2021 Q1 | 40.46 Million NOK | 1716.54% |
| 2021 Q4 | 36.14 Million NOK | 45.12% |
| 2020 FY | 92.31 Million NOK | 58.22% |
| 2020 Q4 | -2.5 Million NOK | -109.34% |
| 2020 Q3 | 26.81 Million NOK | -33.9% |
| 2020 Q2 | 40.56 Million NOK | 47.79% |
| 2020 Q1 | 27.44 Million NOK | 91.61% |
| 2019 Q1 | 13.05 Million NOK | 20.45% |
| 2019 FY | 58.34 Million NOK | 23.09% |
| 2019 Q4 | 14.32 Million NOK | -16.75% |
| 2019 Q3 | 17.2 Million NOK | 25.03% |
| 2019 Q2 | 13.76 Million NOK | 5.42% |
| 2018 FY | 47.4 Million NOK | 5.91% |
| 2018 Q1 | 11.47 Million NOK | 73.09% |
| 2018 Q4 | 10.83 Million NOK | -30.24% |
| 2018 Q3 | 15.53 Million NOK | 62.7% |
| 2018 Q2 | 9.54 Million NOK | -16.81% |
| 2017 Q3 | 10.44 Million NOK | -22.62% |
| 2017 Q2 | 13.49 Million NOK | 7.0% |
| 2017 Q1 | 12.61 Million NOK | 18.04% |
| 2017 FY | 44.75 Million NOK | -0.91% |
| 2017 Q4 | 6.63 Million NOK | -36.49% |
| 2016 Q4 | 10.68 Million NOK | -1.3% |
| 2016 Q3 | 10.82 Million NOK | 2.46% |
| 2016 Q1 | 13.09 Million NOK | 57.92% |
| 2016 Q2 | 10.56 Million NOK | -19.28% |
| 2016 FY | 45.16 Million NOK | 21.82% |
| 2015 Q2 | 9 Million NOK | -6.19% |
| 2015 FY | 37.07 Million NOK | 68.63% |
| 2015 Q4 | 8.28 Million NOK | -18.62% |
| 2015 Q1 | 9.59 Million NOK | 62.35% |
| 2015 Q3 | 10.18 Million NOK | 13.13% |
| 2014 Q4 | 5.91 Million NOK | 5.72% |
| 2014 FY | 21.98 Million NOK | 12.17% |
| 2014 Q3 | 5.59 Million NOK | -21.45% |
| 2014 Q2 | 7.11 Million NOK | 111.62% |
| 2014 Q1 | 3.36 Million NOK | -31.71% |
| 2013 Q3 | 5.68 Million NOK | 56.42% |
| 2013 Q4 | 4.92 Million NOK | -13.37% |
| 2013 FY | 19.6 Million NOK | -0.48% |
| 2013 Q1 | 5.35 Million NOK | -9.28% |
| 2013 Q2 | 3.63 Million NOK | -32.12% |
| 2012 Q1 | 6.27 Million NOK | 113.5% |
| 2012 Q4 | 5.9 Million NOK | 68.8% |
| 2012 Q3 | 3.49 Million NOK | -12.97% |
| 2012 FY | 19.69 Million NOK | -6.89% |
| 2012 Q2 | 4.01 Million NOK | -36.01% |
| 2011 Q4 | 2.94 Million NOK | -39.02% |
| 2011 Q1 | 8.32 Million NOK | -14.51% |
| 2011 Q2 | 5.06 Million NOK | -39.1% |
| 2011 Q3 | 4.82 Million NOK | -4.83% |
| 2011 FY | 21.15 Million NOK | -12.66% |
| 2010 Q4 | 9.73 Million NOK | 381.45% |
| 2010 Q2 | 6.57 Million NOK | 18.15% |
| 2010 Q1 | 5.56 Million NOK | 0.0% |
| 2010 Q3 | 2.02 Million NOK | -69.25% |
| 2010 FY | 24.21 Million NOK | 8.25% |
| 2009 FY | 22.37 Million NOK | -52.24% |
| 2008 FY | 46.84 Million NOK | -17.84% |
| 2007 FY | 57.01 Million NOK | -1.3% |
| 2006 FY | 57.76 Million NOK | 4.16% |
| 2005 FY | 55.45 Million NOK | -58.63% |
| 2004 FY | 134.04 Million NOK | 134.36% |
| 2003 FY | 57.19 Million NOK | 928.13% |
| 2002 FY | 5.56 Million NOK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Arctic Bioscience AS | 9.77 Million NOK | -1056.31% |
| Aqua Bio Technology ASA | 607.92 Thousand NOK | -18489.896% |
| BerGenBio ASA | 354 Thousand NOK | -31824.576% |
| Hofseth BioCare ASA | 29.87 Million NOK | -278.261% |
| PCI Biotech Holding ASA | 2.99 Million NOK | -3679.699% |
| Thor Medical ASA | - NOK | -Infinity% |
| Ultimovacs ASA | -2.76 Million NOK | 4182.84% |